Neville Rodie & Shaw Inc. Cuts Stake in Willis Towers Watson Public Limited Company $WTW

Key Points

• Neville Rodie & Shaw Inc. has reduced its stake in Willis Towers Watson by 40% in Q2, holding 1,698 shares valued at approximately $520,000.
• The company reported $2.86 EPS for Q2, surpassing analysts' expectations of $2.65, while revenue slightly declined by 0.2% year-over-year.
• Willis Towers Watson declared a quarterly dividend of $0.92 per share, reflecting an annualized distribution of $3.68 and a yield of 1.1%.

Neville Rodie & Shaw Inc. decreased its holdings in Willis Towers Watson Public Limited Company (NASDAQ:WTW - Free Report) by 40.0% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,698 shares of the company's stock after selling 1,134 shares during the period. Neville Rodie & Shaw Inc.'s holdings in Willis Towers Watson Public were worth $520,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in the business. Central Pacific Bank Trust Division purchased a new stake in shares of Willis Towers Watson Public in the 2nd quarter valued at $199,000. Confluence Investment Management LLC boosted its stake in shares of Willis Towers Watson Public by 2.0% in the 2nd quarter. Confluence Investment Management LLC now owns 3,388 shares of the company's stock valued at $1,038,000 after purchasing an additional 65 shares in the last quarter. Swedbank AB boosted its stake in shares of Willis Towers Watson Public by 21.6% during the first quarter. Swedbank AB now owns 19,917 shares of the company's stock valued at $6,731,000 after purchasing an additional 3,536 shares during the period. Strs Ohio purchased a new stake in shares of Willis Towers Watson Public during the first quarter valued at approximately $2,065,000. Finally, Advisors Capital Management LLC boosted its stake in shares of Willis Towers Watson Public by 2.0% during the first quarter. Advisors Capital Management LLC now owns 4,101 shares of the company's stock valued at $1,386,000 after purchasing an additional 80 shares during the period. Hedge funds and other institutional investors own 93.09% of the company's stock.

Willis Towers Watson Public Stock Performance

Shares of WTW stock opened at $338.79 on Friday. The stock has a fifty day moving average of $321.58 and a 200 day moving average of $317.63. Willis Towers Watson Public Limited Company has a 52 week low of $286.00 and a 52 week high of $344.14. The firm has a market capitalization of $33.05 billion, a price-to-earnings ratio of 232.05, a PEG ratio of 2.71 and a beta of 0.71. The company has a quick ratio of 1.90, a current ratio of 1.90 and a debt-to-equity ratio of 0.58.

Willis Towers Watson Public (NASDAQ:WTW - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $2.86 EPS for the quarter, topping analysts' consensus estimates of $2.65 by $0.21. Willis Towers Watson Public had a return on equity of 21.60% and a net margin of 1.40%.The company had revenue of $2.26 billion during the quarter, compared to analyst estimates of $2.23 billion. During the same quarter last year, the firm posted $2.55 earnings per share. The firm's revenue was down .2% on a year-over-year basis. As a group, research analysts expect that Willis Towers Watson Public Limited Company will post 17.32 earnings per share for the current year.

Willis Towers Watson Public Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Tuesday, September 30th will be issued a $0.92 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $3.68 dividend on an annualized basis and a yield of 1.1%. Willis Towers Watson Public's dividend payout ratio is 252.05%.

Analysts Set New Price Targets

A number of analysts have recently weighed in on WTW shares. Morgan Stanley increased their price objective on Willis Towers Watson Public from $335.00 to $345.00 and gave the company an "equal weight" rating in a research note on Monday, August 18th. Barclays dropped their price objective on Willis Towers Watson Public from $316.00 to $305.00 and set an "underweight" rating for the company in a research note on Monday, July 7th. Citigroup started coverage on Willis Towers Watson Public in a research note on Wednesday, August 13th. They set a "neutral" rating and a $351.00 price objective for the company. Wells Fargo & Company dropped their price objective on Willis Towers Watson Public from $387.00 to $369.00 and set an "overweight" rating for the company in a research note on Thursday, July 10th. Finally, Cantor Fitzgerald began coverage on Willis Towers Watson Public in a research note on Wednesday, August 13th. They set a "neutral" rating and a $355.00 price objective for the company. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Willis Towers Watson Public has an average rating of "Moderate Buy" and an average price target of $362.92.

Willis Towers Watson Public Profile

Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. It operates through two segments: Health, Wealth & Career and Risk & Broking. The company offers strategy and design consulting, plan management service and support, broking and administration services for health, wellbeing, and other group benefit program, including medical, dental, disability, life, voluntary benefits and other coverages; actuarial support, plan design, and administrative services for pension and retirement savings plans; retirement consulting services and solutions; and integrated solutions that consists of investment discretionary management, pension administration, core actuarial, and communication and change management assistance services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.